title: Activated prothrombin complex concentrate for dabigatran-associated bleeding.
authors.affiliation: Department of Medicine, McMaster University, Hamilton, ON, Canada. schulms@mcmaster.ca.
authors.forename: Sam
authors.initials: S
authors.lastname: Schulman
authors.forename: Bruce
authors.initials: B
authors.lastname: Ritchie
authors.forename: Jennifer K
authors.initials: JK
authors.lastname: Goy
authors.forename: Susan
authors.initials: S
authors.lastname: Nahirniak
authors.forename: Mohammad
authors.initials: M
authors.lastname: Almutawa
authors.forename: Shari
authors.initials: S
authors.lastname: Ghanny
mesh_terms: D000369:Aged, 80 and over; D000991:Antithrombins / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects*; D001921:Brain / Q000473:pathology; D000069604:Dabigatran; D005260:Female; D006408:Hematoma, Subdural / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy; D006470:Hemorrhage / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011516:Prothrombin / Q000008:administration & dosage*; D014057:Tomography, X-Ray Computed; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D011516:Prothrombin; D000069604:Dabigatran
keywords: bleeding activated prothrombin complex concentrate; dabigatran